Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment.

A research team at the University of Würzburg has, for the first time, uncovered how E. coli bacteria sneak into the prostate ...

A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new ...

A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, some unique to specific groups.

Probiotics and broccoli could help to slow the spread of prostate cancer, research suggests. Broccoli, turmeric, pomegranate, green tea, ginger and cranberry were combined in a supplement and given to ...

For nearly a decade, Dr. Cong Li, Dr. Lingming Liang, and Ms. Fei Lee have worked together at Amgen’s research laboratories in San Francisco to develop a new generation of potential therapies for ...

Today, a patient diagnosed with advanced prostate cancer has options. Doctors can offer a suite of androgen-suppressing drugs to extend his life. There are genetic tests that can show whether he’s a ...

Men with prostate cancer who were “fast metabolizers” of caffeine from coffee tended to have better prostate cancer-specific survival, according to recent research. How quickly a person’s body can ...

A newly developed long-term prediction model demonstrated greater accuracy in estimating prostate cancer–specific mortality compared with existing risk assessment tools. Unlike traditional ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

The prognosis of grade group 1 prostate cancer varies widely, with high-risk features increasing the possibility of adverse pathology, biochemical recurrence, and in some cases, death. Gleason grade ...